急诊科轻度创伤性脑损伤患者创伤性颅内出血的危险因素:系统评价与Meta分析
该系统评价与Meta分析纳入17篇文献、共26,040例轻度创伤性脑损伤(mTBI,入院GCS 13-15)患者,其中2,054例(7.9%)经CT证实存在创伤性颅内出血(tICH)。汇总分析显示,颅底骨折征象(OR 11.71,95%CI 5.51-24.86)、GCS<15(OR 4.69,95%CI 2.76-7.98)、意识丧失(OR 2.57,95%CI 1.83-3.61)、创伤后遗忘(OR 2.13,95%CI 1.27-3.57)、创伤后呕吐(OR 2.04,95%CI 1.11-3.76)、抗血小板治疗(OR 1.54,95%CI 1.10-2.15)和男性(OR 1.28,95%CI 1.11-1.49)为tICH的显著预测因素。抗凝药物使用、头痛和中毒未显示预测作用。作者认为现有急诊指南存在改进空间,并需要更好的前瞻性试验,同时考虑该领域的通用数据元素。
要点
- 在mTBI(GCS 13-15)患者中,颅底骨折征象与tICH风险升高相关(OR 11.71,95%CI 5.51-24.86),GCS<15亦相关(OR 4.69,95%CI 2.76-7.98)。
- 意识丧失(OR 2.57,95%CI 1.83-3.61)、创伤后遗忘(OR 2.13,95%CI 1.27-3.57)和创伤后呕吐(OR 2.04,95%CI 1.11-3.76)与tICH风险升高相关。
- 抗血小板治疗(OR 1.54,95%CI 1.10-2.15)和男性(OR 1.28,95%CI 1.11-1.49)与tICH风险升高相关。
- 抗凝药物使用、头痛和中毒未显示与tICH风险相关。
- 作者认为现有急诊指南存在改进空间,并需要更好的前瞻性试验,同时考虑该领域的通用数据元素。
适用人群与场景
- 轻度创伤性脑损伤(mTBI)患者,定义为入院格拉斯哥昏迷评分(GCS)13-15分。
- 急诊科(ED)就诊场景。
诊断标准与关键阈值
- mTBI诊断标准:创伤性脑损伤(TBI)且入院GCS 13-15分。
- 结局指标:CT证实的创伤性颅内出血(tICH)。
红旗征与不能漏的情况
- 颅底骨折征象(OR 11.71,95%CI 5.51-24.86)与tICH风险升高相关。
- GCS<15(OR 4.69,95%CI 2.76-7.98)与tICH风险升高相关。
研究设计与关键结果
- 系统评价与Meta分析,纳入17篇文献,汇总患者26,040例,其中2,054例(7.9%)经CT证实tICH。
- 颅底骨折征象:OR 11.71,95%CI 5.51-24.86;GCS<15:OR 4.69,95%CI 2.76-7.98;意识丧失:OR 2.57,95%CI 1.83-3.61;创伤后遗忘:OR 2.13,95%CI 1.27-3.57;创伤后呕吐:OR 2.04,95%CI 1.11-3.76;抗血小板治疗:OR 1.54,95%CI 1.10-2.15;男性:OR 1.28,95%CI 1.11-1.49。
- 抗凝药物使用、头痛和中毒未显示预测tICH。
证据类型、等级与局限
- 系统评价与Meta分析(PROSPERO注册号CRD42023392495)。
- 局限:研究间存在多种异质性来源;需要更好的前瞻性试验,并考虑该领域的通用数据元素。
对床旁实践的改变
- 作者认为,与颅底骨折征象和GCS降低不同,急诊指南中使用的抗凝药物使用、头痛和中毒等要素未显示预测tICH。
- 作者认为,现有指南存在改进空间,并需要更好的前瞻性试验,同时考虑该领域的通用数据元素。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Mild traumatic brain injury (mTBI), i.e. a TBI with an admission Glasgow Coma Scale (GCS) of 13-15, is a common cause of emergency department visits. Only a small fraction of these patients will develop a traumatic intracranial hemorrhage (tICH) with an even smaller subgroup suffering from severe outcomes. Limitations in existing management guidelines lead to overuse of computed tomography (CT) for emergency department (ED) diagnosis of tICH which may result in patient harm and higher healthcare costs.
OBJECTIVE: To perform a systematic review and meta-analysis to characterize known and potential novel risk factors that impact the risk of tICH in patients with mTBI to provide a foundation for improving existing ED guidelines.
METHODS: The literature was searched using MEDLINE, EMBASE and Web of Science databases. Reference lists of major literature was cross-checked. The outcome variable was tICH on CT. Odds ratios (OR) were pooled for independent risk factors.
RESULTS: After completion of screening, 17 papers were selected for inclusion, with a pooled patient population of 26,040 where 2,054 cases of tICH were verified through CT (7.9%). Signs of a skull base fracture (OR 11.71, 95% CI 5.51-24.86), GCS < 15 (OR 4.69, 95% CI 2.76-7.98), loss of consciousness (OR 2.57, 95% CI 1.83-3.61), post-traumatic amnesia (OR 2.13, 95% CI 1.27-3.57), post-traumatic vomiting (OR 2.04, 95% CI 1.11-3.76), antiplatelet therapy (OR 1.54, 95% CI 1.10-2.15) and male sex (OR 1.28, 95% CI 1.11-1.49) were determined in the data synthesis to be statistically significant predictors of tICH.
CONCLUSION: Our meta-analysis provides additional context to predictors associated with high and low risk for tICH in mTBI. In contrast to signs of a skull base fracture and reduction in GCS, some elements used in ED guidelines such as anticoagulant use, headache and intoxication were not predictive of tICH. Even though there were multiple sources of heterogeneity across studies, these findings suggest that there is potential for improvement over existing guidelines as well as a the need for better prospective trials with consideration for common data elements in this area. PROSPERO registration number CRD42023392495.
参考来源
- Yang LJ, Lassarén P, Londi F, et al. Risk factors for traumatic intracranial hemorrhage in mild traumatic brain injury patients at the emergency department: a systematic review and meta-analysis. Scand J Trauma Resusc Emerg Med. 2024. PMID: 39289729. doi:10.1186/s13049-024-01262-6
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。